Dong, C. Cytokine regulation and function in T cells. Annu. Rev. Immunol. 39, 51–76 (2021).
Voskoboinik, I., Whisstock, J. C. & Trapani, J. A. Perforin and granzymes: function, dysfunction and human pathology. Nat. Rev. Immunol. 15, 388–400 (2015).
Aubert, A., Jung, K., Hiroyasu, S., Pardo, J. & Granville, D. J. Granzyme serine proteases in inflammation and rheumatic diseases. Nat. Rev. Rheumatol. 20, 361–376 (2024).
Donado, C. A. et al. Granzyme K activates the entire complement cascade. Nature 641, 211–221 (2025).
Lan, F. et al. GZMK-expressing CD8(+) T cells promote recurrent airway inflammatory diseases. Nature 638, 490–498 (2025).
Guo, C. L. et al. Granzyme K(+)CD8(+) T cells interact with fibroblasts to promote neutrophilic inflammation in nasal polyps. Nat. Commun. 15, 10413 (2024).
Guo, X. et al. Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer. Cancer Cell 43, 248–268.e9 (2025).
Guo, C. L., Wang, C. S., Wang, X. H., Yu, D. & Liu, Z. GZMK(+)CD8(+) T cells: multifaceted roles beyond cytotoxicity. Trends Immunol. 46, 562–572 (2025).
Kwek, S. S. et al. Identification and regulation of circulating tumor-TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancer. JCI Insight 10, e177373 (2025).
Koga, R. et al. Granzyme K- and amphiregulin-expressing cytotoxic T cells and activated extrafollicular B cells are potential drivers of IgG4-related disease. J. Allergy Clin. Immunol. 153, 1095–1112 (2024).
Aoyagi, R. et al. Single-cell transcriptomics reveals granzyme K-expressing cytotoxic Tfh cells in tertiary lymphoid structures in IgG4-RD. J. Allergy Clin. Immunol. 153, 513–520.e10 (2024).
Elyahu, Y. et al. Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Sci. Adv. 5, eaaw8330 (2019).
Magen, A. et al. Intratumoral dendritic cell-CD4(+) T helper cell niches enable CD8(+) T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nat. Med. 29, 1389–1399 (2023).
Nie, H. et al. Single-cell meta-analysis of inflammatory bowel disease with scIBD. Nat. Comput. Sci. 3, 522–531 (2023).
Fenton, C. G., Taman, H., Florholmen, J., Sorbye, S. W. & Paulssen, R. H. Transcriptional signatures that define ulcerative colitis in remission. Inflamm. Bowel Dis. 27, 94–105 (2021).
Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).
Bai, X. et al. Reciprocal regulation of T follicular helper cells and dendritic cells drives colitis development. Nat. Immunol. 25, 1383–1394 (2024).
Li, Y. et al. Stem-like T cells are associated with the pathogenesis of ulcerative colitis in humans. Nat. Immunol. 25, 1231–1244 (2024).
Reis, B. S., Rogoz, A., Costa-Pinto, F. A., Taniuchi, I. & Mucida, D. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4⁺ T cell immunity. Nat. Immunol. 14, 271–280 (2013).
Mucida, D. et al. Transcriptional reprogramming of mature CD4(+) helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes. Nat. Immunol. 14, 281–289 (2013).
Li, J., He, Y., Hao, J., Ni, L. & Dong, C. High levels of eomes promote exhaustion of anti-tumor CD8(+) T cells. Front. Immunol. 9, 2981 (2018).
Endo, Y. et al. Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3. Immunity 35, 733–745 (2011).
Ichiyama, K. et al. Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of Eomesodermin. Immunity 34, 741–754 (2011).
Lupar, E. et al. Eomesodermin expression in CD4+ T cells restricts peripheral Foxp3 induction. J. Immunol. 195, 4742–4752 (2015).
Johnston, R. J. et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006–1010 (2009).
Sun, Q. et al. BCL6 promotes a stem-like CD8(+) T cell program in cancer via antagonizing BLIMP1. Sci. Immunol. 8, eadh1306 (2023).
Tan, S. N. et al. Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39. J. Exp. Med. 222, e20240445 (2025).
Zander, R., Khatun, A., Kasmani, M. Y., Chen, Y. & Cui, W. Delineating the transcriptional landscape and clonal diversity of virus-specific CD4(+) T cells during chronic viral infection. eLife 11, e80079 (2022).
Zhang, P. et al. Eomesodermin promotes the development of type 1 regulatory T (T(R)1) cells. Sci. Immunol. 2, eaah7152 (2017).
Gruarin, P. et al. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells. Eur. J. Immunol. 49, 96–111 (2019).
Bonnal, R. J. P. et al. Clonally expanded EOMES(+) Tr1-like cells in primary and metastatic tumors are associated with disease progression. Nat. Immunol. 22, 735–745 (2021).
Zhang, P. et al. Eomesodermin+ CD4+ T cells are critical for curative immunotherapy outcomes. Immunity 58, 3024–3039.e7 (2025).
Thelen, B. et al. Eomes is sufficient to regulate IL-10 expression and cytotoxic effector molecules in murine CD4(+) T cells. Front. Immunol. 14, 1058267 (2023).
Ansaldo, E. et al. T-bet-expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape. Proc. Natl Acad. Sci. USA 123, e2520747122 (2026).
Devarajan, P. et al. Cytotoxic CD4 development requires CD4 effectors to concurrently recognize local antigen and encounter type I IFN-induced IL-15. Cell Rep. 42, 113182 (2023).
Marshall, N. B. et al. NKG2C/E marks the unique cytotoxic CD4 T cell subset, ThCTL, generated by influenza infection. J. Immunol. 198, 1142–1155 (2017).
Takeuchi, A. et al. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage. J. Exp. Med. 213, 123–138 (2016).
Mazzoni, A. et al. Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation. Eur. J. Immunol. 49, 79–95 (2019).
Curran, M. A. et al. Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin. J. Exp. Med. 210, 743–755 (2013).
Raveney, B. J. et al. Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation. Nat. Commun. 6, 8437 (2015).
Stienne, C. et al. Foxo3 transcription factor drives pathogenic T helper 1 differentiation by inducing the expression of Eomes. Immunity 45, 774–787 (2016).
Zhang, C. et al. Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation. Proc. Natl Acad. Sci. USA 116, 21131–21139 (2019).
Raveney, B. J. E. et al. Involvement of cytotoxic Eomes-expressing CD4(+) T cells in secondary progressive multiple sclerosis. Proc. Natl Acad. Sci. USA 118, e2021818118 (2021).
Chen, S. et al. Eomesodermin expression in CD4(+) T-cells associated with disease progression in amyotrophic lateral sclerosis. CNS Neurosci. Ther. 30, e14503 (2024).
Joulia, E. et al. Eomes-dependent mitochondrial regulation promotes survival of pathogenic CD4+ T cells during inflammation. J. Exp. Med. 221, e20230449 (2024).
Kanazawa, T. et al. Pathogenic potential of Eomesodermin-expressing T-helper cells in neurodegenerative diseases. Ann. Neurol. 95, 1093–1098 (2024).
Elyahu, Y. et al. CD4 T cells acquire Eomesodermin to modulate cellular senescence and aging. Nat. Aging 5, 1970–1982 (2025).
Roessner, P. M. et al. EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4(+) T cells in chronic lymphocytic leukemia. Leukemia 35, 2311–2324 (2021).
Schnell, A., Littman, D. R. & Kuchroo, V. K. T(H)17 cell heterogeneity and its role in tissue inflammation. Nat. Immunol. 24, 19–29 (2023).
Liu, Z. et al. Epigenetic reprogramming of Runx3 reinforces CD8+ T-cell function and improves the clinical response to immunotherapy. Mol. Cancer 22, 84 (2023).
Chi, X. et al. RORγt expression in mature T(H)17 cells safeguards their lineage specification by inhibiting conversion to T(H)2 cells. Sci. Adv. 8, eabn7774 (2022).
Liu, X. et al. Genome-wide analysis identifies Bcl6-controlled regulatory networks during T follicular helper cell differentiation. Cell Rep. 14, 1735–1747 (2016).
Alquicira-Hernandez, J. & Powell, J. E. Nebulosa recovers single-cell gene expression signals by kernel density estimation. Bioinformatics 37, 2485–2487 (2021).
Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293–304 (2024).
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890 (2018).
Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907–915 (2019).
Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).
Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Xu, S. et al. Using clusterProfiler to characterize multiomics data. Nat. Protoc. 19, 3292–3320 (2024).
Ramirez, F., Dundar, F., Diehl, S., Gruning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187–W191 (2014).
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576–589 (2010).
Wang, Q. et al. Exploring epigenomic datasets by ChIPseeker. Curr. Protoc. 2, e585 (2022).
Xie, T. Processed RNA-seq, ATAC-seq and CUT&Tag data. figshare https://doi.org/10.6084/m9.figshare.30477716 (2026).